MX2019009640A - Ingrediente activo farmaceutico y uso del mismo, en particular, para la prevencion y el tratamiento de trastornos metabolicos en humanos y animales. - Google Patents
Ingrediente activo farmaceutico y uso del mismo, en particular, para la prevencion y el tratamiento de trastornos metabolicos en humanos y animales.Info
- Publication number
- MX2019009640A MX2019009640A MX2019009640A MX2019009640A MX2019009640A MX 2019009640 A MX2019009640 A MX 2019009640A MX 2019009640 A MX2019009640 A MX 2019009640A MX 2019009640 A MX2019009640 A MX 2019009640A MX 2019009640 A MX2019009640 A MX 2019009640A
- Authority
- MX
- Mexico
- Prior art keywords
- prevention
- treatment
- active pharmaceutical
- pharmaceutical ingredient
- humans
- Prior art date
Links
- 239000008186 active pharmaceutical agent Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 title 1
- 208000030159 metabolic disease Diseases 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000023852 carbohydrate metabolic process Effects 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- -1 dihydroxyphenyl Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000037356 lipid metabolism Effects 0.000 abstract 1
- RFWGABANNQMHMZ-ZCHJGGQASA-N oleuropein Chemical compound O([C@@H]\1OC=C([C@H](C/1=C\C)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-ZCHJGGQASA-N 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
La invención se refiere a un ingrediente farmacéutico activo que consiste exclusivamente en la combinación de ácido (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihidroxifenil)-2-propenoil]oxi}-1 ,4,5- trihidroxiciclohexanocarboxílico y metil (2S,3E,4S)-4-{2-[2-(3,4-dihidroxifenil)etoxi]-2-oxoetil}-3- etilideno-2-(ß-D-glucopiranosiloxi)-3,4-dihidro-2H-piran-5-carbox ilato para uso como medicamento o producto veterinario, particularmente en la prevención y/o el tratamiento de trastornos patológicos del metabolismo de carbohidratos y/o lípidos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1770144A FR3062795B1 (fr) | 2017-02-16 | 2017-02-16 | Principe actif pharmaceutique et utilisation en particulier dans la prevention et le traitement des dereglements metaboliques chez l'homme et l'animal. |
| PCT/EP2018/053520 WO2018149812A1 (fr) | 2017-02-16 | 2018-02-13 | Principe actif pharmaceutique et utilisation en particulier dans la prevention et le traitement des dereglements metaboliques chez l'homme et l'animal |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019009640A true MX2019009640A (es) | 2019-10-02 |
| MX380833B MX380833B (es) | 2025-03-11 |
Family
ID=58645316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019009640A MX380833B (es) | 2017-02-16 | 2018-02-13 | Ingrediente activo farmacéutico y uso del mismo, en particular, para la prevención y el tratamiento de trastornos metabólicos en humanos y animales. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11191744B2 (es) |
| EP (1) | EP3582767B1 (es) |
| JP (2) | JP2020509998A (es) |
| KR (1) | KR20190130572A (es) |
| CN (1) | CN110520120A (es) |
| AU (1) | AU2018221616A1 (es) |
| BR (1) | BR112019016945A2 (es) |
| CA (1) | CA3051789A1 (es) |
| ES (1) | ES2879318T3 (es) |
| FR (1) | FR3062795B1 (es) |
| IL (1) | IL268271A (es) |
| MA (1) | MA47498B1 (es) |
| MX (1) | MX380833B (es) |
| PL (1) | PL3582767T3 (es) |
| RU (1) | RU2759903C2 (es) |
| SG (1) | SG11201906907TA (es) |
| WO (1) | WO2018149812A1 (es) |
| ZA (1) | ZA201905309B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11152221B2 (en) | 2019-02-20 | 2021-10-19 | Applied Materials, Inc. | Methods and apparatus for metal silicide deposition |
| IT202100031985A1 (it) * | 2021-12-21 | 2023-06-21 | Innbiotec Pharma S R L | Composizione farmaceutica a base di glutatione tioestere e oleuropeina per l’uso nel trattamento della steatoepatite non alcolica |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070009620A1 (en) * | 2005-07-11 | 2007-01-11 | Yoshinori Aoki | Cholesterol regulating agent |
| JP2007045814A (ja) * | 2005-07-11 | 2007-02-22 | Eisai Food Chemical Kk | コレステロール調節剤 |
| US20090061031A1 (en) * | 2006-07-07 | 2009-03-05 | Sylvia Lee-Huang | Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus |
| CA2705785A1 (en) * | 2006-11-14 | 2008-05-22 | Saul Yedgar | Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| CN100502854C (zh) * | 2007-01-23 | 2009-06-24 | 武汉大学 | 绿原酸在制备抗糖尿病并发症的药中的应用 |
| ITMI20080514A1 (it) * | 2008-03-27 | 2009-09-28 | Univ Firenze | Uso della oleuropeina e suoi derivati nel trattamento del diabete mellito di tipo 2 e di patologie associate a fenomeni di aggregazione di proteine |
| RU2451506C1 (ru) * | 2011-06-02 | 2012-05-27 | Сергей Юрьевич Лешков | Комбинация для лечения сахарного диабета и его осложнений |
| FR3027228B1 (fr) * | 2014-10-20 | 2016-12-09 | Valbiotis | Composition comprenant un melange d'extraits vegetaux et utilisation pour agir sur le metabolisme glucidique et/ou lipidique |
-
2017
- 2017-02-16 FR FR1770144A patent/FR3062795B1/fr not_active Expired - Fee Related
-
2018
- 2018-02-13 MX MX2019009640A patent/MX380833B/es unknown
- 2018-02-13 ES ES18708058T patent/ES2879318T3/es active Active
- 2018-02-13 CN CN201880012259.4A patent/CN110520120A/zh active Pending
- 2018-02-13 AU AU2018221616A patent/AU2018221616A1/en not_active Abandoned
- 2018-02-13 EP EP18708058.5A patent/EP3582767B1/fr active Active
- 2018-02-13 CA CA3051789A patent/CA3051789A1/fr active Pending
- 2018-02-13 SG SG11201906907TA patent/SG11201906907TA/en unknown
- 2018-02-13 WO PCT/EP2018/053520 patent/WO2018149812A1/fr not_active Ceased
- 2018-02-13 US US16/486,381 patent/US11191744B2/en not_active Expired - Fee Related
- 2018-02-13 RU RU2019125320A patent/RU2759903C2/ru active
- 2018-02-13 PL PL18708058T patent/PL3582767T3/pl unknown
- 2018-02-13 KR KR1020197026951A patent/KR20190130572A/ko not_active Abandoned
- 2018-02-13 JP JP2019541135A patent/JP2020509998A/ja not_active Abandoned
- 2018-02-13 MA MA47498A patent/MA47498B1/fr unknown
- 2018-02-13 BR BR112019016945A patent/BR112019016945A2/pt not_active IP Right Cessation
-
2019
- 2019-07-25 IL IL268271A patent/IL268271A/en unknown
- 2019-08-12 ZA ZA2019/05309A patent/ZA201905309B/en unknown
-
2022
- 2022-09-16 JP JP2022147843A patent/JP2022180477A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200009101A1 (en) | 2020-01-09 |
| RU2019125320A3 (es) | 2021-05-20 |
| ES2879318T3 (es) | 2021-11-22 |
| WO2018149812A1 (fr) | 2018-08-23 |
| JP2022180477A (ja) | 2022-12-06 |
| JP2020509998A (ja) | 2020-04-02 |
| FR3062795B1 (fr) | 2019-06-07 |
| PL3582767T3 (pl) | 2021-11-08 |
| ZA201905309B (en) | 2020-05-27 |
| AU2018221616A1 (en) | 2019-08-08 |
| RU2019125320A (ru) | 2021-03-16 |
| EP3582767B1 (fr) | 2021-04-07 |
| US11191744B2 (en) | 2021-12-07 |
| SG11201906907TA (en) | 2019-08-27 |
| KR20190130572A (ko) | 2019-11-22 |
| RU2759903C2 (ru) | 2021-11-18 |
| CN110520120A (zh) | 2019-11-29 |
| CA3051789A1 (fr) | 2018-08-23 |
| MA47498B1 (fr) | 2021-08-31 |
| IL268271A (en) | 2019-09-26 |
| EP3582767A1 (fr) | 2019-12-25 |
| BR112019016945A2 (pt) | 2020-04-14 |
| FR3062795A1 (fr) | 2018-08-17 |
| MX380833B (es) | 2025-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2524320T3 (es) | Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo | |
| MX2016000307A (es) | Farmaco para el tratamiento de la esteatosis hepatica no alcoholica. | |
| BR112015014372A8 (pt) | inibidores de autotaxina, seus usos, e composição e combinação farmacêuticas". | |
| EP4559902A3 (en) | Kdm1a inhibitors for the treatment of disease | |
| NZ631100A (en) | Soft chewable pharmaceutical products | |
| AR098576A1 (es) | Producto farmacéutico | |
| MX357780B (es) | Derivados policíclicos, proceso para su preparación y su uso farmacéutico. | |
| BR112015019412A2 (pt) | inibidores de bace1 | |
| CO2020000240A2 (es) | Combinación que comprende palbociclib y ácido 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxílico | |
| AR104068A1 (es) | Combinaciones de un compuesto inhibidor de fosfoinosítido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cáncer | |
| BR112015029897A2 (pt) | composição sólida para administração oral contendo ácido ibandrônico ou um seu sal farmaceuticamente aceitável e vitamina d e processo para obtenção da referida composição | |
| MX2017011499A (es) | Combinaciones de dosis fija y formulaciones que comprenden ácido 8-hidroxi-2,2,14,14 tetrametilpentadecanodioico (etc1002) y ezetimiba y métodos para tratar o reducir el riesgo de enfermedad cardiovascular. | |
| PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
| MX2022003969A (es) | Composiciones degustables que incluyen fenilbutirato de sodio y usos de las mismas. | |
| UY28209A1 (es) | Derivados de aminoácidos con cicloalquilo, procedimiento para su preparación y su uso como medicamentos. | |
| MX384072B (es) | Compuesto derivado de pirrolo-piridina, metodo para preparar el mismo y composicion farmaceutica que contiene el mismo como ingrediente activo para la prevencion o el tratamiento de enfermedades relacionadas con la proteina cinasa. | |
| MX2019009640A (es) | Ingrediente activo farmaceutico y uso del mismo, en particular, para la prevencion y el tratamiento de trastornos metabolicos en humanos y animales. | |
| CL2018000391A1 (es) | Combinaciones farmacéuticas y su uso | |
| EP2722322A4 (en) | 1,3-DI-OXO-INDEN DERIVATIVE, PHARMACEUTICALLY ALLOWED SALT AND OPTICAL ISOMER THEREOF, METHOD OF MANUFACTURING THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THIS DERIVATIVE AS AN ANTIVIRAL ACTIVE SUBSTANCE | |
| PA8596701A1 (es) | Derivados de aminoacidos sustituidos con cicloalquilo, procedimiento para su preparacion y su uso como medicamentos | |
| MX2020004105A (es) | Formulacion farmaceutica. | |
| EP2873419A4 (en) | PHARMACEUTICAL COMPOSITION WITH AZATHIOPRINE AS ACTIVE AGENT FOR PREVENTION TREATMENT OF BRAIN TUMORS OR TEMODAL RESISTANT GLIOBLASTOMES | |
| EP4023647A4 (en) | IMIDAZOPYRIDINL DERIVATIVES AND PHARMACEUTICAL COMPOSITION WITH THEM AS AN ACTIVE SUBSTANCE | |
| SV2017005527A (es) | Agente terapéutico para disfunción del lóbulo frontal | |
| BR112015015493A2 (pt) | composição farmacêutica que contém um derivado de n-fenilpirazol e de permetrina, uso para a preparação de um medicamento veterinário tópico |